Skip to main content
High RiskFDAfda-F-1229-2019CONTAMINATION

Frozen IQF Strawberries packed in a flexible polybag. Each bag is 2 lbs (906.5g), 6 bags per case. UPC is UPC: 0 22518 87710 3. The...

Category
Units Affected
1,448
Recall Date
February 7, 2019
Issuing Agency
Hazard
Contamination

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1229-2019.

Frozen IQF strawberries are recalled due to potential contamination with Hepatitis A virus.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1229-2019.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Willamette Valley Pie Company, Llc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1229-2019.

Willamette Valley Pie Company, LLC.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Willamette Valley Pie Company, Llc. Recall FAQ

Willamette Valley Pie Company, Llc. is the subject of a produce safety report: Frozen IQF Strawberries packed in a flexible polybag. Each bag is 2 lbs (906.5g), 6 bags per case. UPC is UPC: 0 22518 87710 3. The.... The notice was published on February 7, 2019 by the U.S. Food and Drug Administration (FDA). Approximately 1,448 units are potentially affected.